Navigation Links
BRL in Medical News

Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA

... MONTVALE, N.J., Dec. 11 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Duramed Pharmaceuticals, Inc.'s Adenovirus Types 4 and 7 Li...

FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream

...- Further Expands Company's Hormone Therapy Product Line MONTVALE, N.J., Dec. 1 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (N...

Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg

... MONTVALE, N.J., Nov. 26 /PRNewswire/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Anesta in connection with its Amrix(...

Barr Shareholders Approve Pending Teva Acquisition

... MONTVALE, N.J., Nov. 21 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today announced that its shareholders overwhelmingly approved the proposals submitted to them relating to the acquisition of Barr by Teva Pharmaceut...

Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation

...ment of patent litigation brought by Sanofi-Aventis (NYSE: SNY ) against Barr Laboratories, Inc. a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: brl ). The suit was brought in the U.S. District Court of Delaware 2006 based upon Barr's filing of an ANDA for Triamcinolone Acetonide Nasal Spray conta...

Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges

...nc. Related to Generic Versions of Allegra(R) Tablets MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today announced that its subsidiary, Barr Laboratories, Inc. has entered into separate settlement agreements related to ongoing patent challenges fo...

Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL

... MONTVALE, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today announced that its subsidiary, PLIVA - Lachema a.s., has received final approval from the U.S. Food and Drug Administration (FDA) for its gene...

Teva and Barr Receive FTC Request for Additional Information

...ALEM and MONTVALE, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) and Barr Pharmaceuticals, Inc. (NYSE: brl ) announced today that, as expected, each party has received a request for additional information (commonly referred to as a "second request") from th...

Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges

... MONTVALE, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve...

Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets

... MONTVALE, N.J., July 31 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today confirmed that its subsidiaries, Barr Laboratories, Inc. and PLIVA-Hrvatska D.O.O., have initiated a challenge of the patent listed by UCB Inc...
BRL in Medical Products

Replacement Bulb: BRL

Description: Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discount light bulbs specials. Check our web site for additional brands and prices....
Company:Bulb Direct, Inc.
BRL in Biological Technology

Teva and Barr Provide Update on Acquisition

...rael and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) and Barr Pharmaceuticals, Inc. (NYSE: brl ) announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities t...

FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive

...tended-Cycle Oral Contraceptive for the Prevention of Pregnancy MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (N...

Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules

... MONTVALE, N.J., Sept. 16 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today announced that its subsidiary, Barr Laboratories, Inc., received final approval from the U.S. Food & Drug Administration (FDA) to manufacture ...

Barr Receives Approval for Generic Version of Razadyne(R) Tablets

... MONTVALE, N.J., Aug. 28 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today announced that its subsidiary, Barr Laboratories, Inc., received final approval from the U.S. Food & Drug Administration (FDA) to manufacture ...

Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share

...- Company Reiterates 2008 Adjusted EPS Guidance of $2.75 - $3.05 MONTVALE, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today reported net earnings of $57 million, or $0.52 per share, on revenues of $779 million for the quarter ended June 30, 2008. The current quarter...

Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg

... MONTVALE, N.J., July 29 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Amgen Inc. in connection with its S...

Teva to Acquire Barr

...ALEM and MONTVALE, N.J., July 18 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) and Barr Pharmaceuticals, Inc. (NYSE: brl ) announced today that they have signed a definitive agreement under which Teva will acquire Barr, the fourth largest generic drug company worldwide. ...

Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge

... MONTVALE, N.J., June 26 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent ...

Barr Confirms Patent Challenge of Prevacid(R) SoluTab(TM) Delayed-Release Orally Disintegrating Tablets, 15mg and 30mg

... MONTVALE, N.J., June 10 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by TAP Pharmaceuticals Inc. in connect...

Barr Confirms Patent Challenge of Entocort(R), 3mg Enteric Coated Capsules

... MONTVALE, N.J., May 27 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: brl ) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by AstraZeneca LP in connection with i...
BRL in Biological Dictionary

RT-PCR

...anscriptase- PCR ... The following is a great RT - PCR protocol I obtained from David Klein at NIH. ... 2.0 ul SuperScript II RT (200 U/ul)(Gibco brl ... The latest PCR platforms, fluorescent chemistries, validation software, data ... a comprehensive overview of the RT - PCR technology, which...
Other Tags
(Date:7/4/2015)... ... ... Chronic Neck Pain. Neck pain is no small problem. NIH ... Another 19% suffer from head, migraine, or facial pain, in some cases related to ... workers must deal with neck pain. Strategies for mitigating neck pain range ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... for enrollment on July 2nd creating a buzz of media attention. In an ... published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling ...
(Date:7/3/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. ... To be held from March 4th - 6th, the 2016 (a previous announcement had ... , Designed to take participants from the basic training and fundamentals of nasal surgery ...
(Date:7/3/2015)... Orange, CT (PRWEB) , ... July 03, 2015 , ... ... at home is a good blender and easily accessible, quality ingredients. Aurora Natural is ... your smoothie for an added boost of fiber, protein, antioxidants, vitamins and minerals! , ...
(Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part ... to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the ... , Almost every smartphone has an incredibly powerful camera built into it. And when ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Learn How to Take Selfies like Kendall Jenner 2
(Date:6/17/2015)... , June 17, 2015 QIAGEN ... launched new Investigator ® STR assay kits for analysis ... United States . The new genetic fingerprint kits provide ... (short tandem repeats or STRs) for DNA matching. They incorporate ... of DNA in each sample, a novel QIAGEN technology that ...
(Date:6/16/2015)... 2015 /CNW Telbec/ - handyem Inc. and FlowMetric ... incorporation of handyem,s HPC-150 portable flow cytometer within ... This unprecedented model of mobile laboratory platform is ... Pennsylvania Convention Center, ... to 18 th 2015.  By virtue ...
(Date:6/16/2015)... GOTHENBURG, Sweden , June 16, 2015 ... 2015 from previously communicated that it will amount to at ... 390 MSEK. Due to the rapid increase in market growth ... from the previously communicated guidance that revenue for 2015 will ... 2015 will amount to approximately 2,200 MSEK. Due ...
Breaking Biology News(10 mins):QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
Other Contents